Home| About us| My LA: login/register| For authors| For reviewers| Submit a paper
(close)

(Ctrl-click to select multiple journals)


How should we address you?

Your email address


 Yes, sign up now
 Sign up for general news too

Privacy Statement
 
 
 

Clinical Medicine: Psychiatry

Synopsis: An open access, peer reviewed electronic journal that covers diagnosis, management and prevention of psychiatric disorders.


Indexing: Indexed by Google Scholar.  Pubmed indexing for NIH-funded research.

Processing time: Decision in 2 weeks for 90% of papers.

Visibility: Most popular article read 400+ times.

View factor
for journal
17085


About this journal

ISSN: 1178-6590


Aims and scope:

Clinical Medicine: Psychiatry is an international, open access, peer reviewed journal which considers manuscripts on all aspects of the diagnosis, management and prevention of psychiatric disorders, in addition to related genetic, pathophysiological and epidemiological topics.

Editorial standards and procedures:

Submissions, excluding editorials, letters to the editor and dedications, will be peer reviewed by two reviewers.  Reviewers are required to provide fair, balanced and constructive reports.  

Under our Fairness in Peer Review Policy authors may appeal against reviewers' recommendations which are ill-founded, unobjective or unfair.  Appeals are considered by the Editor in Chief or Associate Editor.

Papers are not sent to peer reviewers following submission of a revised manuscript. Editorial decisions on re-submitted papers are based on the author's response to the initial peer review report.

Indexing:

This journal is indexed by:

  • Google Scholar

National Institutes of Health Public Access Policy compliant:

As of April 7 2008, the US NIH Public Access Policy requires that all peer reviewed articles resulting from research carried out with NIH funding be deposited in the Pubmed Central archive.

If you are an NIH employee or grantee Libertas Academica will ensure that you comply with the policy by depositing your paper at Pubmed Central on your behalf. 



Editor in Chief's call for papers
 
 
 


Anthroposophic Therapy for Anxiety Disorders: A Two-year Prospective Cohort Study in Routine Outpatient Settings

Authors: Harald J. Hamre, Claudia M. Witt, Gunver S. Kienle, Anja Glockmann, Renatus Ziegler, Stefan N. Willich and Helmut Kiene
Publication Date: 10 Jun 2009
Clinical Medicine: Psychiatry 2009:2 17-31

Harald J. Hamre1, Claudia M. Witt2, Gunver S. Kienle1, Anja Glockmann1, Renatus Ziegler3, Stefan N. Willich2 and Helmut Kiene1

1Institute for Applied Epistemology and Medical Methodology, Freiburg, Germany. 2Institute of Social Medicine, Epidemiology, and Health Economics, Charité University Medical Center, Berlin, Germany. 3Society for Cancer Research, Arlesheim, Switzerland.

Abstract

Background and Methods: Anthroposophic treatment for anxiety disorders includes special artistic and physical therapies and special medications. We conducted a prospective cohort study of 64 consecutive adult outpatients starting anthroposophic treatment for anxiety disorders under routine conditions. Main outcomes were Anxiety Severity (physician and patient ratings 0–10), Self-rating Anxiety Scale (0–100), Center for Epidemiological Studies Depression Scale, German version (CES-D, 0–60), and SF-36 Mental Component Summary.

Results: Mean age was 42.3 years. Most frequent diagnoses were generalized anxiety disorder (44% of patients, n = 28/64) and panic disorder (39%). Median disease duration was 4.5 years. The anthroposophic treatment modalities used were medications (56% of patients), eurythmy therapy (41%), art therapy (30%), and rhythmical massage therapy (3%). Median number of eurythmy/art/massage sessions was 12, median therapy duration was 120 days.
From baseline to six-month follow-up, all outcomes improved significantly; average improvements were: Physician-rated Anxiety Severity 3.60 points (95% confidence interval 2.97–4.22, p < 0.001), patient-rated Anxiety Severity 3.50 (2.88–4.12, p < 0.001), Self-rating Anxiety Scale 11.88 (7.70–16.05, p < 0.001), CES-D 8.79 (5.61–11.98, p < 0.001), and SF-36 Mental Component 9.53 (5.98–13.08, p < 0.001). All improvements were maintained until last follow-up after 24 months.

Conclusions: Patients with anxiety disorders under anthroposophic treatment had long-term improvements of symptoms and quality of life.

Categories: Psychiatry


Post comment




No comments yet...Be the first to comment.

Bookmark this article

LINKEDIN FACEBOOK

Add to Mixx! MIXX YAHOO! BUZZ

PERMALINK DIGG


Sign up for free journal updates

How should we address you?
Your email address
 Yes, sign up now


Recently published in this journal

Anthroposophic Therapy for Anxiety Disorders: A Two-year Prospective Cohort Study in Routine Outpatient Settings
- 10/Jun/2009

Database Analysis of Adults with Bipolar Disorder Consuming a Micronutrient Formula
- 01/Apr/2009

Introductory Editorial (Clinical Medicine: Psychiatry)
- 19/Jan/2009

Metabolic Implications of Psychotropic Medications in a Publicly-Funded State Psychiatric Hospital
- 07/Aug/2008

Association of Parental Psychiatric Morbidity with their Altruistic Behaviors and Sense of Obligation to Children in the United States
- 21/Jul/2008

Relationship Between Perceived Sleep Problems and Thalamic Size in Patients with Chronic Fatigue Syndrome Compared to Non-Fatigued Controls: A Preliminary Study
- 18/Jul/2008

Hopelessness and Low Social and Occupational Functioning are Associated with Non-Recovery from Depression – Results of a 6-Year Follow-Up Study
- 21/May/2008



Related journals...